Cocaine is a significant risk factor for contracting HIV-1 infection and subsequently developing AIDS. The proposed research is aimed to dissect the role of cocaine and HIV-associated epigenetic mechanisms in the development of HIV-associated neurocognitive disorders (HAND). In recent years, chromatin remodeling has emerged as an important regulatory mechanism for drug addiction and also in development of neurodegenerative disorders. In the current study, we will focus on HDAC2 since it is known to play a critical role in cognitive function by regulating the density of dendritic spines and influencing synaptic transmission in mature neurons. However, the role of HDAC2 in development of HAND is not elucidated yet in the context of cocaine. In our published and preliminary studies, we found that HIV-1 Tat protein and HIV-1 infection upregulate HDAC2 expression with concomitant downregulation of CREB and CamKIIa and 17 other genes that are known to regulate synaptic plasticity. Further we have shown for the first time that cocaine significantly upregulated HDAC2 gene expression and downregulated miR-155 and transfection with miR-155 significantly inhibited HIV infection. Accordingly, we hypothesize that cocaine acts a co-factor in neuropathogenesis of HIV infection by modulating HDAC2 expression in CNS cells leading to transcriptional repression of genes that regulate neuronal activity and synaptic plasticity. The specific goals are to determine: 1) whether cocaine in association with HIV-1 virus modulates HDAC2 which in turn negatively regulates synaptic plasticity/ memory genes in primary human microglia, hippocampal neurons and astrocytes thereby contributing to the progression of HAND; 2) whether inhibition of HDAC2 reverses the effects of cocaine and HIV-1 virus on neuronal plasticity genes and dendritic spine density and 3) can delivery of HDAC2 specific siRNA and miR-155 across the in vitro blood-brain barrier (BBB) model and in HIV-E SCID cocaine mouse model using transferrin coupled liposomal nanoformulation be explored as a therapeutic strategy for HAND. Thus, an understanding of cocaine and HIV-associated epigenetic changes and its implications in neuropathogenesis will have translational significance for therapeutic targeting and control of HAND in HIV-infected cocaine users.

Public Health Relevance

The proposed research will elucidate the cocaine and HIV-associated epigenetic mechanisms in the development of HIV-associated neurocognitive disorders (HAND). Further, we will also evaluate the efficacy of transferrin coupled liposomal nanoformulation to transmigrate across an in vitro blood-brain barrier (BBB) model as well as in the HIV-E SCID cocaine mouse model. These studies will have translational significance for therapeutic targeting and control of HAND in cocaine abusing HIV-infected patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA034547-05
Application #
9265446
Study Section
NeuroAIDS and other End-Organ Diseases Study Section (NAED)
Program Officer
Wu, Da-Yu
Project Start
2013-03-01
Project End
2018-12-31
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Florida International University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
071298814
City
Miami
State
FL
Country
United States
Zip Code
33199
Hadjikhani, Ali; Rodzinski, Alexa; Wang, Ping et al. (2017) Biodistribution and clearance of magnetoelectric nanoparticles for nanomedical applications using energy dispersive spectroscopy. Nanomedicine (Lond) 12:1801-1822
Nagesetti, Abhignyan; Rodzinski, Alexandra; Stimphil, Emmanuel et al. (2017) Multiferroic coreshell magnetoelectric nanoparticles as NMR sensitive nanoprobes for cancer cell detection. Sci Rep 7:1610
Sagar, Vidya; Nair, Madhavan (2017) Near-infrared biophotonics-based nanodrug release systems and their potential application for neuro-disorders. Expert Opin Drug Deliv :1-16
Kaushik, Ajeet; Tiwari, Sneham; Jayant, Rahul D et al. (2017) Electrochemical Biosensors for Early Stage Zika Diagnostics. Trends Biotechnol 35:308-317
Sagar, Vidya; Pilakka-Kanthikeel, S; Martinez, Paola C et al. (2017) Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. PLoS One 12:e0181642
Rodriguez, Myosotys; Kaushik, Ajeet; Lapierre, Jessica et al. (2017) Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro. J Neuroimmune Pharmacol 12:120-132
Huang, Zaohua; Nair, Madahavan (2017) A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes. Sci Rep 7:5955
Tomitaka, Asahi; Arami, Hamed; Raymond, Andrea et al. (2017) Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain. Nanoscale 9:764-773
Kaushik, Ajeet; Jayant, Rahul D; Nikkhah-Moshaie, Roozbeh et al. (2016) Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep 6:25309
Sagar, Vidya; Atluri, Venkata Subba Rao; Pilakka-Kanthikeel, Sudheesh et al. (2016) Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse. Mol Brain 9:57

Showing the most recent 10 out of 43 publications